Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 14, 2018
Pharmacy Choice - News - Drug Delivery Systems - August 14, 2018

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 142     Next >>     Go To Page:

8/14/18 - Amicus oral Fabry disease drug approved in US [Arab News (Saudi Arabia)]
Amicus Therapeutics first oral drug for the rare condition Fabry disease has been approved by the FDA, giving patients an alternative to conventional injected enzyme replacement therapy. The oral drug is an alternative to the infused enzyme replacement therapy that is current standard of care Sanofi/ Genzymes Fabarazyme. Already approved in Europe,
8/14/18 - Depomed Announces Second-Quarter 2018 Financial Results
LAKE FOREST- Depomed, Inc. today reported financial results for the quarter ended June 30, 2018 and provided an update on its business performance and strategic initiatives. 'I mentioned on our first-quarter earnings conference call that I expected 2018 to be a very busy and productive year,' said Arthur Higgins, President and CEO of Depomed.' With
8/14/18 - FDA approves Amicus` Galafold for Fabry disease [T-break Tech (Middle East)]
The efficacy of Galafold was demonstrated in a six-month, placebo-controlled clinical trial in 45 adults with Fabry disease. The U.S. Food and Drug Administration recently approved Galafold, the first oral medication for the treatment of adults with Fabry disease. Galafold differs from enzyme replacement in that it increases the activity of the bod
8/14/18 - Genacol Canada Corporation and Tetra Bio-Pharma Team Up to bring Innovative Cannabinoid Treatments to Self-Care Market in Canada
Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development, is pleased to announce that they have concluded a Development and Commercialization agreement with Genacol Canada Corporation. Tetra Bio-Pharma will develop a cannabinoid derived oral capsule and a topical cream for treating joint pain and inflammation.
8/14/18 - Genmab Announces Submission of U.S. & EU Regulatory Applications Seeking Approval of DARZALEX Split Dosing Regimen
Copenhagen- Genmab A/S announced today that its licensing partner, Janssen Biotech, Inc., has submitted a supplemental Biologics License Application to the U.S. Food and Drug Administration and a Type II Variation to the European Medicines Agency seeking approval of a split dosing regimen for DARZALEX. In August 2012, Genmab granted Janssen an excl
8/14/18 - Glenmark Pharmaceuticals' partner Elite Pharmaceuticals receives US FDA approval for generic methadone hydrochloride tablets
NORTHVALE- Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, today announced that it received approval from the U.S. Food and Drug Administration for the Company's abbreviated new drug application for methadone hydrochloride 5 mg and 10 mg tablets. Based on QuintilesIMS...
8/14/18 - Halozyme Reports Second Quarter 2018 Results
Second Quarter 2018 and Recent Highlights include: U.S. Food and Drug Administration accepting Roche/ Genentech's Biologics License Application for a subcutaneous formulation of Herceptin in combination with Halozyme's ENHANZE technology in its FDA- approved breast cancer indications. Roche reported total 2017 sales of Herceptin in the United State
8/14/18 - InfuSystem Holdings, Inc. Reports Second Quarter 2018 Financial Results
InfuSystem Holdings, Inc., a leading national provider of infusion pumps and related services for the healthcare industry in the United States and Canada, today reported financial results for the second quarter ended June 30, 2018.. Commenting on the second quarter, Richard DiIorio, Chief Executive Officer of InfuSystem, said, I am pleased to
8/14/18 - Injectable Drug Delivery Market Is Expected to Expand at a CAGR of 10.9% over the Forecast Period, 20182028.: Future Market Insights has announced the addition of the Injectable Drug Delivery Market is expected to expand at a CAGR of 10.9% ove
Valley Cottage, NY 08/14/2018 According to the latest report published by Future Market Insights, titled' Global Injectable Drug Delivery Market: Global Industry Analysis 2013 2017 and Opportunity Assessment, 2018 2028', the Global injectable drug delivery market is expected to expand at a CAGR of 10.9% over the forecast period, 2018
8/14/18 - Investigators at Shanghai Jiao-Tong University Report New Data on Drug Delivery Systems (Biodegradable Cyclomatrix Polyphosphazene Nanoparticles: A...
By a News Reporter-Staff News Editor at Cancer Weekly Investigators discuss new findings in Drugs and Therapies- Drug Delivery Systems. According to news originating from Shanghai, People's Republic of China, by NewsRx correspondents, research stated, "Traditional drug delivery systems suffer from low drug-loading and relatively weak therapeutic.
8/14/18 - Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX Split Dosing Regimen
RARITAN- The Janssen Pharmaceutical Companies of Johnson& Johnson announced today the submission of a supplemental Biologics License Application to the U.S. Food and Drug Administration and a Type II Variation to the European Medicines Agency seeking approval of a split dosing regimen for DARZALEX. In the U.S., DARZALEX first received FDA approval
8/14/18 - Neos Therapeutics Reports Second Quarter 2018 Financial Results
DALLAS- Neos Therapeutics, Inc., a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release products using its proprietary modified-release drug delivery technologies, today reported financial results for the second quarter ended June 30, 2018 and provided a business update.
8/14/18 - Researchers from Trakya University Describe Findings in Drug Delivery Systems (Cytotoxicity of doxrubicin loaded single-walled carbon nanotubes)
By a News Reporter-Staff News Editor at Cancer Weekly Fresh data on Drugs and Therapies- Drug Delivery Systems are presented in a new report. According to news reporting originating in Edirne, Turkey, by NewsRx journalists, research stated, "Carbon nanotube is a new alternative for efficient drug delivery and it has a great potential to change dr
8/14/18 - scPharmaceuticals Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update
scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced financial results for the second quarter ended June 30, 2018 and provided a business update.. Since receivin
8/14/18 - Studies from University of Southern Denmark Have Provided New Information about Drug Delivery Systems [Black Phosphorus Quantum Dots Gated,...
Studies from University of Southern Denmark Have Provided New Information about Drug Delivery Systems. By a News Reporter-Staff News Editor at Cancer Weekly A new study on Drugs and Therapies- Drug Delivery Systems is now available. The news correspondents obtained a quote from the research from the University of Southern Denmark, "BPQDs and carb
8/14/18 - Titan Pharmaceuticals Reports Second Quarter 2018 Financial Results
Titan Pharmaceuticals, Inc., a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura? long-term, continuous drug delivery technology, today reported financial results for the second quarter ended June 30, 2018, and provided an update on its business. In May 2018, Titan announced the appo
8/14/18 - US Med-Equip Earns Prestigious Supplier Excellence Award from HealthTrust
US Med-Equip primarily serves hospitals and long-term acute care centers, renting to them a wide range of moveable equipment across various clinical applications, including respiratory, infusion, patient monitoring, and neonatal. The company was chosen for the award from among hundreds of HealthTrust vendors included in the medical-surgical categor
8/13/18 - "Medical Device Notification System" in Patent Application Approval Process (USPTO 20180207373)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor Morrison, Mark Steven, filed on March 27, 2018, was made available online on July 26, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to MicroDose Therapeutx Inc..
8/13/18 - "Oxymetazoline For The Treatment Of Ano-Rectal Disorders" in Patent Application Approval Process (USPTO 20180207135)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Barak, Nir; Rice, Howard Lawrence, filed on December 8, 2017, was made available online on July 26, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to RDD Pharma Ltd.
8/13/18 - $26 Billion IV Catheters, Needles, and Syringes Market - Global Outlook and Forecast Report 2018-2023
The "IV Catheters, Needles, and Syringes Market- Global Outlook and Forecast 2018-2023" report has been added to ResearchAndMarkets.com' s offering. The global IV catheters, needles, and syringes market are anticipated to reach values of over $26 billion by 2023, growing at a CAGR of more than 7% during 2017-2023.. The growing demand for safety IV
8/13/18 - $26 Billion IV Catheters, Needles, and Syringes Market - Global Outlook and Forecast Report 2018-2023 - ResearchAndMarkets.com
The "IV Catheters, Needles, and Syringes Market- Global Outlook and Forecast 2018-2023" report has been added to ResearchAndMarkets.com' s offering. The global IV catheters, needles, and syringes market are anticipated to reach values of over $26 billion by 2023, growing at a CAGR of more than 7% during 2017-2023.. The growing demand for safety IV
8/13/18 - 60 Degrees Pharma`s malaria drug Arakoda receives US FDA approal [Arab Finance (Egypt)]
60 Degrees Pharmaceuticals has announced the US Food and Drug Administration approval of Arakoda tablets for the prevention of malaria in patients aged 18 years and older. For the first time in more than eighteen years, the US FDA approved a new drug for the prevention of malaria. "We have worked closely with the US Army as their commercial partne
8/13/18 - Catalyst Biosciences Announces Oral Presentation at the 2018 Hemophilia Drug Development Summit
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology indications, today announced that Dr. Howard Levy, chief medical officer of Catalyst, will deliver an oral presentation at the 2018 Hemophilia Drug Development Summit being held in Boston on August 14-16, 2018..
8/13/18 - Data on Drug Delivery Systems Described by X.Y. Jiang et al [Microfluidics for producing poly (lactic-co-glycolic acid)-based Check for...
Data on Drug Delivery Systems Described by X.Y. Jiang et al. According to news reporting originating in Beijing, People's Republic of China, by NewsRx journalists, research stated, "Microfluidic chips allow the rapid production of a library of nanoparticles with distinct properties by changing the precursors and the flow rates, significantly decrea
8/13/18 - Drug Delivery Systems Market Is Expected to Surpass 6.9% by 2025
Albany, NY 08/13/2018 Drug Delivery Systems Market: Snapshot. The global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. For instance, on September 2017, Baxter International Inc. announced the launch of De
Articles(s): 1 - 25 of 142     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415